B7H3-ATI020(Anwita)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameB7H3-ATI020(Anwita)
Drug Alias NameB7H3-ATI020B7H3 ATI020B7H3ATI020
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CD276
TargetsCD276 antigen
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnwita Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnwita Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A